Chidzidzo chakazvimiririra kubva kuGermany chinosimbisa kuti bimodal neuromodulation inogona kuderedza zvakanyanya zviratidzo zvetinnitus mumamiriro ekiriniki epasirese.
Kambani yeIrish yemishonga yezvokurapa, Neuromod Devices Ltd. (Neuromod), yakagamuchira zvakawanikwa zvekudzidza kwakazvimiririra kwakaitwa kuGermany Hearing Center (DHZ) paHannover Medical School, iyo yakawana kuti 85% yevarwere vetinnitus vakawana kuderedzwa kwezviratidzo zvavo zvetinnitus. (zvichibva paTinnitus Handicap Inventory mamakisi[i] pavarwere ve20) kana uchishandisa mudziyo wekurapa weLenire.
Ichi chidzidzo chakaratidza kuti mavhiki matanhatu kusvika ku12 ekurapa achishandisa Lenire, bimodal neuromodulation device yakagadzirwa neNeuromod inopa ruzha uye magetsi ekusimudzira rurimi, inogona kuwana zvakachengeteka kukiriniki kunobatsira kuvandudzwa kwechiratidzo chetinnitus muhutano hwemakiriniki chaiwo.
Chidzidzo chacho chaitungamirirwa naDr. Thomas Lenarz, Anke Lesinski-Schiedat, uye Andreas Buechner kubva kuDhipatimendi reOtolaryngology paHannover Medical School, Germany.
Mhedzisiro iyi ichangobva kuburitswa mupepanhau resainzi rine chinzvimbo chepamusoro, Brain Stimulation[ii].
Iyo chaiyo-yenyika data inopindirana nemhedzisiro yeNeuromod's yakakura-scale kiriniki yekuedza (TENT-A1), iyo yaisanganisira 326 vatori vechikamu. Muyedzo weTENT-A1, mhedzisiro yacho yakaburitswa muna Gumiguru 2020[iii], yakaratidza kuti 86.2% yevatori vechikamu vanoteera kurapwa vakashuma kuvandudzwa kwezviratidzo zvavo zvetinnitus mushure menguva yegumi nemaviri-vhiki vachishandisa Lenire.
Chidzidzo cheHannover chaisanganisira nguva shomanana yekurapa (6-12 mavhiki) uye yakacherechedza kuvandudzwa kunoreva (kuderedza) muTHI chikamu che10.4 points, iyo inopfuura mutsauko unokosha wekliniki we7 points. Iyi data yepasirese kubva kuHannover yekudzidza inoenderana neTENT-A1 kudzidza, iyo yakaona kuvandudzwa kwakafanana mushure memavhiki matanhatu ekurapwa uye yakawana huwandu hwe6 point kuvandudzwa mushure memavhiki gumi nemaviri ekurapa. Uyezve, pakanga pasina zviitiko zvakashata zvine chekuita nekurapa.
Lenire anoshanda nekuunza mapuruzi emagetsi akapfava kururimi, kuburikidza nechikamu chemukati-mumuromo chinonzi 'Tonguetip', yakasanganiswa neruzha rwunoridzwa nemahedhifoni kutyaira shanduko yenguva refu kana neuroplasticity muuropi kurapa tinnitus.
Muedzo wekiriniki weTENT-A1, uyo waisanganisira vatori vechikamu mazana matatu nemakumi maviri nevatanhatu muIreland yose neGermany, wakaratidza hunyanzvi hwaLenire mukuvandudza zviratidzo zvemudzidzi. 326% yevatori vechikamu-vanopindirana nekurapa vakashuma kuvandudzwa kwezviratidzo zvavo zvetinnitus mushure me86.2-vhiki yekurapa nguva[iv]. Kana yakateverwa nemwedzi ye12 mushure mekurapwa, 12% yevatori vechikamu vanoteerera kurapwa vakatsigira kuvandudzwa kwezviratidzo zvavo zvetinnitus.
Chidzidzo cheTENT-A1 chinomiririra imwe yemakiriniki makuru uye akareba akateedzerwa akamboitwa mumunda wetinnitus uye yaive nyaya yekuvharisa yejenari resainzi Science Translational Medicine muna Gumiguru 2020.
Neuromod inyanzvi mune isiri-invasive neuromodulation tekinoroji uye yakagadzira nekugadzira Lenire, iyo yakashandiswa kurapa tinnitus varwere kubvira 2019.
ZVOKUBVA MUNYAYA INO:
- (Neuromod), has welcomed the findings of an independent study performed at the German Hearing Center (DHZ) at Hannover Medical School, which found that 85% of tinnitus patients experienced a reduction in their tinnitus symptoms (based on the Tinnitus Handicap Inventory score[i] across 20 patients) when using the Lenire treatment device.
- Ichi chidzidzo chakaratidza kuti mavhiki matanhatu kusvika ku12 ekurapa achishandisa Lenire, bimodal neuromodulation device yakagadzirwa neNeuromod inopa ruzha uye magetsi ekusimudzira rurimi, inogona kuwana zvakachengeteka kukiriniki kunobatsira kuvandudzwa kwechiratidzo chetinnitus muhutano hwemakiriniki chaiwo.
- Chidzidzo cheTENT-A1 chinomiririra imwe yemakiriniki makuru uye akareba akateedzerwa akamboitwa mumunda wetinnitus uye yaive nyaya yekuvharisa yejenari resainzi Science Translational Medicine muna Gumiguru 2020.
